Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?

scientific article

Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe? is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1080/07357900500449694
P698PubMed publication ID16466993

P50authorHeinz-Josef LenzQ89668545
P2093author name stringAnthony B El-Khoueiry
P2860cites workDesign of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissueQ27863454
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR studyQ28189472
Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapyQ30433652
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancerQ33978749
Optimal use of the combination of irinotecan and 5-fluorouracilQ35152551
5-Fluorouracil by Protracted Venous Infusion: A Review of Recent Clinical StudiesQ36810361
5-Fluorouracil by protracted venous infusion. A review of current progressQ38653866
A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinomaQ43819026
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer GasQ44578293
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysisQ45057200
The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells.Q52162964
Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays.Q54510265
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectfluorouracilQ238512
P304page(s)50-55
P577publication date2006-02-01
P1433published inCancer InvestigationQ325953
P1476titleShould continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?
P478volume24

Reverse relations

cites work (P2860)
Q64273134Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil
Q38938577Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.
Q39996690Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors
Q46844116In-vitro and in-vivo studies of pectin/ethylcellulosefilm-coated pellets of 5-fluorouracil for colonic targeting
Q33866280Inhibition of human gastric carcinoma cell growth by atofluding derivative N3-o-toluyl-fluorouracil
Q36840074Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategies
Q33788372N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.
Q39566084Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.
Q36634272The new era in the treatment of advanced colorectal cancer patients: the role of monoclonal antibodies.

Search more.